| 481 |
CYPRESS |
CYPROTERONE ACETATE PH.EUR 2 MG, ETHINYLESTRADIOL PH.EUR 0.035 MG |
FILM COATED TABLET |
ALU/PVDC |
TREATMENT OF MODERATE TO SEVERE ACNE RELATED TO ANDROGEN-SENSITIVITY (WITH OR WITHOUT SEBORRHOEA) AND/OR HIRSUTISM, IN WOMEN OF REPRODUCTIVE AGE. FOR THE TREATMENT OF ACNE, CYPRESS SHOULD ONLY BE USED AFTER THERAPY OR SYSTEMIC ANTIBIOTIC TREATMENTS HAVE FAILED |
No |
DKSH LAOS COMPANY LIMITED |
MYLAN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
01 I 5665/24 |
2024-01-26 |
2027-01-25 |
View |
| 482 |
DAISY P |
DESOGESTREL PH.EUR 150 MCG, ETHINYLESTRADIOL PH.EUR 30 MCG |
TABLET |
ALU-PVC/PVDC |
ORAL CONTRACEPTION |
No |
DKSH LAOS COMPANY LIMITED |
MYLAN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
05 I 5515/23 |
2023-05-15 |
2026-05-14 |
View |
| 483 |
DALACIN T |
CLINDAMYCIN PHOSPHATE EQ. TO CLINDAMYCIN 10 MG/ML |
TOPICAL SOLUTION |
BOTTLE |
ACNE VULGARIS |
No |
DKSH LAOS COMPANY LIMITED |
OLIC (THAILAND) LIMITED |
THAILAND |
CERTIFICATE RELEASED |
11 I 3995/13 |
2024-06-22 |
2027-06-21 |
View |
| 484 |
DEMOTHINE INJECTION 100 MG/ 2 ML |
PETHIDINE HYDROCHLORIDE 100 MG/ 2 ML |
SOLUTION FOR INJECTION |
AMPOULES |
FOR RELIEF OF MODERATE TO SEVERE PAIN NOT RESPONSIVE TO NOB-NARCOTIC ANALGESICS. IT MAY ALSO BE USED AS PRE-OPERATIVE MEDICATION AND AS AN ANALGESIC ADJUNCT IN GENERAL ANAESTHESIA AND TO PROVIDE OBSTETRICAL ANALGESIA |
Yes |
DKSH LAOS COMPANY LIMITED |
DUOPHARMA (M) SDN BHD |
MALAYSIA |
CERTIFICATE RELEASED |
06 I 5541/23 |
2023-06-26 |
2026-06-25 |
View |
| 485 |
PARACETAMOL INJECTION |
PARACETAMOL 1 G/100 ML |
SOLUTION FOR INJECTION |
BOTTLE |
FOR THE MANAGEMENT OF MILD TO MODERATE PAIN IN ADULT AND PAEDIATRIC PATIENTS 2 YEARS AND OLDER, REDUCTION OF FEVER IN ADULT AND PAEDIATRIC PATIENTS |
Yes |
VIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY |
CISEN PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
12 I 5833/24 |
2024-12-16 |
2029-12-15 |
View |
| 486 |
NEWCHOICE |
EACH HORMONE FILM COATED TABLET CONTAINS: LEVONOGESTREL 0.125 MG, ETHINYLESTRADIOL 0.03 MG. EACH IRON FILM COATED TABLET CONTAINS: FERROUS FUMARATE 75 MG |
FILM COATED TABLET |
PVC-ALU BLISTERPACK |
ORAL CONTRACEPTION |
No |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
NAM HA PHARMACEUTICAL JOINT STOCK COMPANY |
VIETNAM |
CERTIFICATE RELEASED |
01 I 5873/25 |
2025-01-31 |
2030-01-30 |
View |
| 487 |
DEPO-PROVERA |
MEDROXYPROGESTERONE ACETATE 150 MG/ML |
SUSPENSION FOR INJECTION |
VIAL |
FOR LONG - TERM FEMALE CONTRACEPTION, DEPO-PROVERA IS SUITABLE FOR USE IN WOMEN WHO HAVE BEEN APPROPRIATELY CONSELLED CONCERNING THE LIKELIHOOD OF MENSTRUAL DISTURBANCE AND THE POTENTIAL FOR A DELAY IN RETURN TO FULL FERTILITY. |
No |
DKSH LAOS COMPANY LIMITED |
PFIZER MANUFACTURING BELGIUM NV |
BELGIUM |
CERTIFICATE RELEASED |
07 I 5256/22 |
2022-08-17 |
2025-08-16 |
View |
| 488 |
DILANTIN (INFATAB) |
PHENYTOIN 50 MG |
TABLET |
BOTTLE |
PHENYTOIN IS INDICATED FOR THE CONTROL OF GENERALIZED TONIC-CLONIC ( GRAND MAL) AND COMPLEX PARTIAL (PSYCHOMOTOR, TEMPORAL LOBE) SEIZURES AND PREVENTION AND TREATMENT OF SEIZURES OCCURRING DURING OR FOLLOWING NEUROSURGERY. |
Yes |
DKSH LAOS COMPANY LIMITED |
OLIC (THAILAND) LIMITED |
THAILAND |
CERTIFICATE RELEASED |
11 I 3996/13 |
2024-09-25 |
2029-09-24 |
View |
| 489 |
DYMISTA |
AZELASTINE HYDROCHLORIDE 137 MCG, FLUTICASONE PROPIONATE 50 MCG |
NASAL SPRAY |
BOTTLE |
RELIEF OF SYMPTOMS OF MODERATELY SEVERE TO SEVERE SEASONAL AND PARENNIAL ALLERGIC RHINITIS IF MONOTHERAPY WITH EITHER INTRANASAL ANTIHISTAMINE OR GLUCOCORTICOID IS NOT CONSIDERED SUFFICIENT |
No |
DKSH LAOS COMPANY LIMITED |
CIPLA LIMITED |
GERMANY |
CERTIFICATE RELEASED |
04 I 5478/23 |
2023-04-25 |
2026-04-24 |
View |
| 490 |
DYNAPAR GEL |
OLEUM LINI (LINSEED OIL BP) CONTAINING PREDOMINANTLY ALPHA LINOLENIC ACID) 3 % W/W, DICLOFENAC DIETHYLAMINE BP 1.16 % W/W EQ.TO DICLOFENAC SODIUM 1 %W/W, METHYL SALICYLATE BP 10 % W/W, MENTHOL USP 5 %W/W. |
GEL |
TUBE |
FOR THE LOCAL SYMPTOMATIC RELIEF OF PAIN AND INFLAMMATION IN TRAUMA OF THE TENDONS, LIGAMENTS, MUSCLES AND JOINTS. LOCALISED FORMS OF SOFT TISSUE RHEUMATISM, IT IS RECOMMENDED THAT TREATMENT BE REVIEWED AFTER 14 DAYS IN THESE INDICATIONS. FOR THE TREATMENT OF OSTEOARTHRITIS OF SUPERFICIAL JOINTS SUCH AS THE KNEE, IN THE TREATMENT OF OSTEOARTHRITIS, THERAPY SHOULD BE REVIEW AFTER 4 WEEKS |
No |
DKSH LAOS COMPANY LIMITED |
TROIKAA PHARMACEUTICALS LIMITED |
INDIA |
CERTIFICATE RELEASED |
05 I 5093/21 |
2024-04-08 |
2027-04-07 |
View |
